Cibc World Market Inc. Grows Stock Position in Kenvue Inc. $KVUE

Cibc World Market Inc. boosted its position in Kenvue Inc. (NYSE:KVUE) by 112.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 684,567 shares of the company’s stock after buying an additional 361,589 shares during the period. Cibc World Market Inc.’s holdings in Kenvue were worth $11,111,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the company. AlphaCore Capital LLC boosted its holdings in shares of Kenvue by 9.9% in the second quarter. AlphaCore Capital LLC now owns 5,287 shares of the company’s stock valued at $111,000 after acquiring an additional 476 shares in the last quarter. Empirical Finance LLC boosted its holdings in Kenvue by 1.8% in the 2nd quarter. Empirical Finance LLC now owns 28,309 shares of the company’s stock valued at $593,000 after purchasing an additional 491 shares in the last quarter. Altus Wealth Group LLC increased its position in Kenvue by 1.7% during the 2nd quarter. Altus Wealth Group LLC now owns 31,398 shares of the company’s stock worth $657,000 after purchasing an additional 524 shares during the period. J.W. Cole Advisors Inc. increased its position in Kenvue by 3.8% during the 2nd quarter. J.W. Cole Advisors Inc. now owns 15,488 shares of the company’s stock worth $324,000 after purchasing an additional 574 shares during the period. Finally, Spire Wealth Management raised its stake in shares of Kenvue by 13.5% during the 2nd quarter. Spire Wealth Management now owns 4,863 shares of the company’s stock worth $102,000 after buying an additional 580 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Kenvue Stock Performance

NYSE:KVUE opened at $18.70 on Friday. The company has a current ratio of 0.98, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. The firm has a 50-day moving average price of $17.38 and a two-hundred day moving average price of $17.76. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $25.17. The company has a market capitalization of $35.82 billion, a P/E ratio of 24.93 and a beta of 0.59.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th will be paid a $0.2075 dividend. The ex-dividend date of this dividend is Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a yield of 4.4%. Kenvue’s dividend payout ratio is presently 110.67%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Canaccord Genuity Group reaffirmed a “hold” rating and set a $15.00 price objective (down previously from $26.00) on shares of Kenvue in a report on Wednesday, October 29th. Jefferies Financial Group cut shares of Kenvue from a “buy” rating to a “hold” rating and lowered their price target for the stock from $23.00 to $18.00 in a research note on Friday, January 30th. Evercore set a $18.00 price objective on shares of Kenvue in a research note on Tuesday, October 28th. Deutsche Bank Aktiengesellschaft set a $18.00 target price on shares of Kenvue in a research report on Friday, October 24th. Finally, Johnson Rice reaffirmed a “neutral” rating on shares of Kenvue in a report on Tuesday, October 28th. Four analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. According to MarketBeat.com, Kenvue has a consensus rating of “Hold” and a consensus price target of $19.46.

Insider Buying and Selling

In related news, Director Jeffrey C. Smith purchased 3,200,000 shares of the company’s stock in a transaction on Friday, December 12th. The stock was bought at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the transaction, the director owned 27,307,632 shares of the company’s stock, valued at approximately $474,333,567.84. This represents a 13.27% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.68% of the company’s stock.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.